{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:43:54Z","timestamp":1793947434563,"version":"4.8.0"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:00:00Z","timestamp":1769299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Breast cancer remains a leading cause of morbidity and mortality among women worldwide, with significant heterogeneity in its development and treatment response. Recent advances in understanding the roles of the microbiome and epigenetic regulation have opened new avenues for addressing the complexities of breast cancer progression and therapeutic resistance. This review explores the intricate relationship between the gut and intratumoral microbiomes and epigenetic modifications, such as DNA methylation, histone modifications, and non-coding RNAs. Specifically, we examine how microbial metabolites, particularly short-chain fatty acids (SCFAs), regulate gene expression via epigenetic mechanisms, influencing tumor growth, metastasis, and treatment response. The impact of metabolic diseases, including obesity and type 2 diabetes mellitus (T2DM), on breast cancer risk through microbiome-mediated epigenetic changes is also discussed. Furthermore, the review highlights emerging therapeutic strategies that integrate microbiome modulation with epigenetic therapies, including the use of probiotics, dietary interventions, and fecal microbiota transplantation (FMT), as well as DNA methyltransferase (DNMT) inhibitors and histone deacetylase (HDAC) inhibitors. These innovative approaches hold promise for overcoming treatment resistance and improving clinical outcomes in breast cancer patients. Future research should focus on elucidating the molecular pathways through which the microbiome influences epigenetic regulation and developing personalized, microbiome-targeted therapies that enhance the efficacy of existing treatments. By targeting both the genetic and epigenetic drivers of breast cancer, microbiome-based interventions represent a novel frontier in the fight against this challenging disease.<\/jats:p>","DOI":"10.1186\/s13148-025-02046-0","type":"journal-article","created":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T02:54:20Z","timestamp":1769309660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Targeting microbiome-driven epigenetic modifications: a new frontier in breast cancer treatment"],"prefix":"10.1186","volume":"18","author":[{"given":"Yuhan","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7209-9869","authenticated-orcid":false,"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,25]]},"reference":[{"issue":"1","key":"2046_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13058-023-01636-1","volume":"25","author":"SY Cohen","year":"2023","unstructured":"Cohen SY, et al. Modifiable risk factors in women at high risk of breast cancer: a systematic review. Breast Cancer Res. 2023;25(1):45.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"2046_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1158\/2159-8290.CD-22-0475","volume":"13","author":"SS Onkar","year":"2023","unstructured":"Onkar SS, et al. The great immune escape: understanding the divergent immune response in breast cancer subtypes. Cancer Discov. 2023;13(1):23\u201340.","journal-title":"Cancer Discov"},{"issue":"15","key":"2046_CR3","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.3390\/cancers15154005","volume":"15","author":"RS Lee","year":"2023","unstructured":"Lee RS, et al. Emerging role of epigenetic modifiers in breast cancer pathogenesis and therapeutic response. Cancers (Basel). 2023;15(15):4005.","journal-title":"Cancers (Basel)"},{"issue":"23","key":"2046_CR4","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/s41388-024-03054-9","volume":"43","author":"C Das","year":"2024","unstructured":"Das C, et al. A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance. Oncogene. 2024;43(23):1727\u201341.","journal-title":"Oncogene"},{"key":"2046_CR5","doi-asserted-by":"publisher","first-page":"1325615","DOI":"10.3389\/fimmu.2023.1325615","volume":"14","author":"J Yin","year":"2023","unstructured":"Yin J, et al. Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications. Front Immunol. 2023;14:1325615.","journal-title":"Front Immunol"},{"key":"2046_CR6","doi-asserted-by":"publisher","first-page":"111619","DOI":"10.1016\/j.biopha.2021.111619","volume":"139","author":"R Mirzaei","year":"2021","unstructured":"Mirzaei R, et al. Role of microbiota-derived short-chain fatty acids in cancer development and prevention. Biomed Pharmacother. 2021;139:111619.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"2046_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.33073\/pjm-2022-019","volume":"71","author":"Z Ma","year":"2022","unstructured":"Ma Z, Qu M, Wang X. Analysis of gut microbiota in patients with breast cancer and benign breast lesions. Pol J Microbiol. 2022;71(2):217\u201326.","journal-title":"Pol J Microbiol"},{"issue":"3","key":"2046_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s10096-020-04036-x","volume":"40","author":"C He","year":"2021","unstructured":"He C, et al. Changes of intestinal microflora of breast cancer in premenopausal women. Eur J Clin Microbiol Infect Dis. 2021;40(3):503\u201313.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"2046_CR9","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.3390\/nu13082705","volume":"13","author":"C Bobin-Dubigeon","year":"2021","unstructured":"Bobin-Dubigeon C, et al. Faecal microbiota composition varies between patients with breast cancer and healthy women: a comparative case-control study. Nutrients. 2021;13(8):2705.","journal-title":"Nutrients"},{"issue":"7","key":"2046_CR10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3920\/BM2019.0034","volume":"10","author":"A Horigome","year":"2019","unstructured":"Horigome A, et al. Association between blood omega-3 polyunsaturated fatty acids and the gut microbiota among breast cancer survivors. Benef Microbes. 2019;10(7):751\u20138.","journal-title":"Benef Microbes"},{"issue":"21","key":"2046_CR11","doi-asserted-by":"publisher","first-page":"5364","DOI":"10.3390\/cancers13215364","volume":"13","author":"N Honor\u00e9","year":"2021","unstructured":"Honor\u00e9 N, et al. Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact. Cancers (Basel). 2021;13(21):5364.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"2046_CR12","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3390\/ijerph15081747","volume":"15","author":"MF Fern\u00e1ndez","year":"2018","unstructured":"Fern\u00e1ndez MF, et al. Breast Cancer and Its Relationship with the Microbiota. Int J Environ Res Public Health. 2018;15(8):1747.","journal-title":"Int J Environ Res Public Health"},{"issue":"6494","key":"2046_CR13","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman D, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368(6494):973\u201380.","journal-title":"Science"},{"key":"2046_CR14","doi-asserted-by":"publisher","first-page":"1143163","DOI":"10.3389\/fonc.2023.1143163","volume":"13","author":"Y Wang","year":"2023","unstructured":"Wang Y, et al. Intra-tumoral microbial community profiling and associated metabolites alterations of TNBC. Front Oncol. 2023;13:1143163.","journal-title":"Front Oncol"},{"issue":"5","key":"2046_CR15","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1158\/2159-8290.CD-20-0537","volume":"11","author":"S Parida","year":"2021","unstructured":"Parida S, et al. A procarcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates Notch and \u03b2-catenin axes. Cancer Discov. 2021;11(5):1138\u201357.","journal-title":"Cancer Discov"},{"issue":"1","key":"2046_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1186\/s12885-023-10844-z","volume":"23","author":"G Li","year":"2023","unstructured":"Li G, et al. Fusobacterium nucleatum-derived small extracellular vesicles facilitate tumor growth and metastasis via TLR4 in breast cancer. BMC Cancer. 2023;23(1):473.","journal-title":"BMC Cancer"},{"issue":"8","key":"2046_CR17","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","volume":"185","author":"A Fu","year":"2022","unstructured":"Fu A, et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell. 2022;185(8):1356-1372.e26.","journal-title":"Cell"},{"issue":"2","key":"2046_CR18","doi-asserted-by":"publisher","first-page":"2249143","DOI":"10.1080\/19490976.2023.2249143","volume":"15","author":"X Zhu","year":"2023","unstructured":"Zhu X, et al. Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell. Gut Microbes. 2023;15(2):2249143.","journal-title":"Gut Microbes"},{"issue":"1","key":"2046_CR19","doi-asserted-by":"publisher","first-page":"2221452","DOI":"10.1080\/19490976.2023.2221452","volume":"15","author":"D Nandi","year":"2023","unstructured":"Nandi D, Parida S, Sharma D. The gut microbiota in breast cancer development and treatment: the good, the bad, and the useful! Gut Microbes. 2023;15(1):2221452.","journal-title":"Gut Microbes"},{"issue":"9","key":"2046_CR20","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1038\/s41418-021-00784-1","volume":"28","author":"S Terrisse","year":"2021","unstructured":"Terrisse S, et al. Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment. Cell Death Differ. 2021;28(9):2778\u201396.","journal-title":"Cell Death Differ"},{"issue":"5","key":"2046_CR21","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3390\/cells9051091","volume":"9","author":"S Parida","year":"2020","unstructured":"Parida S, Sharma D. Microbial alterations and risk factors of breast cancer: connections and mechanistic insights. Cells. 2020;9(5):1091.","journal-title":"Cells"},{"issue":"7","key":"2046_CR22","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1080\/01635581.2020.1784444","volume":"73","author":"AG Zengul","year":"2021","unstructured":"Zengul AG, et al. Associations between dietary fiber, the fecal microbiota and estrogen metabolism in postmenopausal women with breast cancer. Nutr Cancer. 2021;73(7):1108\u201317.","journal-title":"Nutr Cancer"},{"issue":"1","key":"2046_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13148-024-01787-8","volume":"16","author":"M Panagopoulou","year":"2024","unstructured":"Panagopoulou M, et al. BRCA1 & BRCA2 methylation as a prognostic and predictive biomarker in cancer: implementation in liquid biopsy in the era of precision medicine. Clin Epigenetics. 2024;16(1):178.","journal-title":"Clin Epigenetics"},{"issue":"2","key":"2046_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/00313020500058623","volume":"37","author":"W Yeo","year":"2005","unstructured":"Yeo W, et al. High frequency of promoter hypermethylation of RASSF1A in tumorous and non-tumourous tissue of breast cancer. Pathology. 2005;37(2):125\u201330.","journal-title":"Pathology"},{"issue":"1","key":"2046_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41392-022-01240-3","volume":"8","author":"H Mei","year":"2023","unstructured":"Mei H, et al. Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignancies. Signal Transduct Target Ther. 2023;8(1):18.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2046_CR26","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1186\/s12885-024-12950-y","volume":"24","author":"F Wu","year":"2024","unstructured":"Wu F, et al. EZH2 mutation is associated with the development of visceral metastasis by enhancing proliferation and invasion and inhibiting apoptosis in breast cancer cells. BMC Cancer. 2024;24(1):1166.","journal-title":"BMC Cancer"},{"issue":"4","key":"2046_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41588-022-01047-6","volume":"54","author":"J Marsolier","year":"2022","unstructured":"Marsolier J, et al. H3K27me3 conditions chemotolerance in triple-negative breast cancer. Nat Genet. 2022;54(4):459\u201368.","journal-title":"Nat Genet"},{"issue":"14","key":"2046_CR28","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.7150\/ijms.102123","volume":"21","author":"H Qian","year":"2024","unstructured":"Qian H, et al. Decoding the promise and challenges of miRNA-based cancer therapies: an essential update on miR-21, miR-34, and miR-155. Int J Med Sci. 2024;21(14):2781\u201398.","journal-title":"Int J Med Sci"},{"issue":"7291","key":"2046_CR29","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08975","volume":"464","author":"RA Gupta","year":"2010","unstructured":"Gupta RA, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):1071\u20136.","journal-title":"Nature"},{"issue":"1","key":"2046_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s43141-021-00169-4","volume":"19","author":"A Ramadan","year":"2021","unstructured":"Ramadan A, et al. Clinical impact of PTEN methylation status as a prognostic marker for breast cancer. J Genet Eng Biotechnol. 2021;19(1):66.","journal-title":"J Genet Eng Biotechnol"},{"issue":"5","key":"2046_CR31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3892\/ijo.2021.5278","volume":"59","author":"MT Vietri","year":"2021","unstructured":"Vietri MT, et al. DNA methylation and breast cancer: a way forward (Review). Int J Oncol. 2021;59(5):98.","journal-title":"Int J Oncol"},{"issue":"42","key":"2046_CR32","doi-asserted-by":"publisher","first-page":"11564","DOI":"10.1021\/acs.langmuir.5b02601","volume":"31","author":"V Raghavan","year":"2015","unstructured":"Raghavan V, et al. Sustained epigenetic drug delivery depletes cholesterol-sphingomyelin rafts from resistant breast cancer cells, influencing biophysical characteristics of membrane lipids. Langmuir. 2015;31(42):11564\u201373.","journal-title":"Langmuir"},{"issue":"3","key":"2046_CR33","doi-asserted-by":"publisher","first-page":"e0282244","DOI":"10.1371\/journal.pone.0282244","volume":"18","author":"W Gong","year":"2023","unstructured":"Gong W, et al. Promoting GSDME expression through DNA demethylation to increase chemosensitivity of breast cancer MCF-7 \/ Taxol cells. PLoS ONE. 2023;18(3):e0282244.","journal-title":"PLoS ONE"},{"key":"2046_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsbmb.2018.05.001","volume":"183","author":"MT Munir","year":"2018","unstructured":"Munir MT, et al. The contribution of cholesterol and epigenetic changes to the pathophysiology of breast cancer. J Steroid Biochem Mol Biol. 2018;183:1\u20139.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"2046_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12964-024-01512-1","volume":"22","author":"AI Ferrer-Diaz","year":"2024","unstructured":"Ferrer-Diaz AI, et al. Revealing role of epigenetic modifiers and DNA oxidation in cell-autonomous regulation of cancer stem cells. Cell Commun Signal. 2024;22(1):119.","journal-title":"Cell Commun Signal"},{"issue":"5","key":"2046_CR36","first-page":"1213","volume":"7","author":"W Shan","year":"2017","unstructured":"Shan W, et al. HDAC2 overexpression correlates with aggressive clinicopathological features and DNA-damage response pathway of breast cancer. Am J Cancer Res. 2017;7(5):1213\u201326.","journal-title":"Am J Cancer Res"},{"issue":"3","key":"2046_CR37","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.celrep.2019.12.056","volume":"30","author":"S Yomtoubian","year":"2020","unstructured":"Yomtoubian S, et al. Inhibition of EZH2 catalytic activity selectively targets a metastatic subpopulation in triple-negative breast cancer. Cell Rep. 2020;30(3):755-770.e6.","journal-title":"Cell Rep"},{"key":"2046_CR38","doi-asserted-by":"publisher","first-page":"989575","DOI":"10.3389\/fphar.2022.989575","volume":"13","author":"GJ Yang","year":"2022","unstructured":"Yang GJ, et al. A state-of-the-art review on LSD1 and its inhibitors in breast cancer: molecular mechanisms and therapeutic significance. Front Pharmacol. 2022;13:989575.","journal-title":"Front Pharmacol"},{"issue":"8","key":"2046_CR39","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.3390\/ijms24087235","volume":"24","author":"J Szczepanek","year":"2023","unstructured":"Szczepanek J, et al. Harnessing epigenetics for breast cancer therapy: the role of DNA methylation, histone modifications, and microRNA. Int J Mol Sci. 2023;24(8):7235.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2046_CR40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s11658-022-00344-6","volume":"27","author":"M Karami Fath","year":"2022","unstructured":"Karami Fath M, et al. The role of epigenetic modifications in drug resistance and treatment of breast cancer. Cell Mol Biol Lett. 2022;27(1):52.","journal-title":"Cell Mol Biol Lett"},{"key":"2046_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.semcancer.2019.12.019","volume":"65","author":"S Gomez","year":"2020","unstructured":"Gomez S, et al. Combining epigenetic and immune therapy to overcome cancer resistance. Semin Cancer Biol. 2020;65:99\u2013113.","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"2046_CR42","doi-asserted-by":"publisher","first-page":"e010294","DOI":"10.1136\/jitc-2024-010294","volume":"13","author":"HD Bear","year":"2025","unstructured":"Bear HD, et al. T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapy. J Immunother Cancer. 2025;13(2):e010294.","journal-title":"J Immunother Cancer"},{"issue":"28","key":"2046_CR43","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1200\/JCO.21.00944","volume":"39","author":"RM Connolly","year":"2021","unstructured":"Connolly RM, et al. E2112: randomized phase III trial of endocrine therapy plus entinostat or placebo in hormone receptor-positive advanced breast cancer. A trial of the ECOG-ACRIN cancer research group. J Clin Oncol. 2021;39(28):3171\u201381.","journal-title":"J Clin Oncol"},{"issue":"10","key":"2046_CR44","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/mc.22402","volume":"55","author":"E Contreras-Leal","year":"2016","unstructured":"Contreras-Leal E, et al. Histone deacetylase inhibitors promote the expression of ATP2A3 gene in breast cancer cell lines. Mol Carcinog. 2016;55(10):1477\u201385.","journal-title":"Mol Carcinog"},{"issue":"1","key":"2046_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.onc.1207020","volume":"23","author":"V Chopin","year":"2004","unstructured":"Chopin V, et al. P21(WAF1\/CIP1) is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells. Oncogene. 2004;23(1):21\u20139.","journal-title":"Oncogene"},{"issue":"11","key":"2046_CR46","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrc.2016.87","volume":"16","author":"ZT Schug","year":"2016","unstructured":"Schug ZT, Vande Voorde J, Gottlieb E. The metabolic fate of acetate in cancer. Nat Rev Cancer. 2016;16(11):708\u201317.","journal-title":"Nat Rev Cancer"},{"key":"2046_CR47","doi-asserted-by":"publisher","first-page":"11960","DOI":"10.1038\/ncomms11960","volume":"7","author":"X Gao","year":"2016","unstructured":"Gao X, et al. Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia. Nat Commun. 2016;7:11960.","journal-title":"Nat Commun"},{"issue":"1","key":"2046_CR48","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13058-025-02111-9","volume":"27","author":"D Verma","year":"2025","unstructured":"Verma D, et al. An enteropathogenic microbial toxin modulates the breast cancer epigenome resulting in concurrent silencing of tumor suppressor genes. Breast Cancer Res. 2025;27(1):163.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"2046_CR49","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1038\/s41467-020-16967-2","volume":"11","author":"L Parhi","year":"2020","unstructured":"Parhi L, et al. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat Commun. 2020;11(1):3259.","journal-title":"Nat Commun"},{"key":"2046_CR50","doi-asserted-by":"publisher","first-page":"1530269","DOI":"10.3389\/fonc.2025.1530269","volume":"15","author":"Y Huang","year":"2025","unstructured":"Huang Y, et al. Fusobacterium nucleatum promotes metastasis of breast cancer via the miR-21-3p\/FOXO3 axis. Front Oncol. 2025;15:1530269.","journal-title":"Front Oncol"},{"key":"2046_CR51","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jare.2023.08.014","volume":"61","author":"S Guo","year":"2024","unstructured":"Guo S, et al. Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma. J Adv Res. 2024;61:165\u201378.","journal-title":"J Adv Res"},{"issue":"4","key":"2046_CR52","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3892\/ijo.2024.5632","volume":"64","author":"J Sun","year":"2024","unstructured":"Sun J, et al. Butyrate as a promising therapeutic target in cancer: from pathogenesis to clinic (Review). Int J Oncol. 2024;64(4):44.","journal-title":"Int J Oncol"},{"issue":"3","key":"2046_CR53","doi-asserted-by":"publisher","first-page":"12","DOI":"10.15698\/cst2023.03.277","volume":"7","author":"S Terrisse","year":"2023","unstructured":"Terrisse S, Zitvogel L, Kroemer G. Impact of microbiota on breast cancer hormone therapy. Cell Stress. 2023;7(3):12\u20139.","journal-title":"Cell Stress"},{"issue":"21","key":"2046_CR54","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.1016\/j.cell.2021.09.019","volume":"184","author":"KC Lam","year":"2021","unstructured":"Lam KC, et al. Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment. Cell. 2021;184(21):5338-5356.e21.","journal-title":"Cell"},{"issue":"3","key":"2046_CR55","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ccell.2024.02.009","volume":"42","author":"A Rosendahl Huber","year":"2024","unstructured":"Rosendahl Huber A, et al. Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer. Cancer Cell. 2024;42(3):487-496.e6.","journal-title":"Cancer Cell"},{"issue":"1","key":"2046_CR56","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41467-017-02651-5","volume":"9","author":"R Fellows","year":"2018","unstructured":"Fellows R, et al. Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases. Nat Commun. 2018;9(1):105.","journal-title":"Nat Commun"},{"issue":"6","key":"2046_CR57","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/procel\/pwae005","volume":"15","author":"W Ma","year":"2024","unstructured":"Ma W, et al. Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1. Protein Cell. 2024;15(6):419\u201340.","journal-title":"Protein Cell"},{"issue":"16","key":"2046_CR58","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1128\/AEM.01235-16","volume":"82","author":"C Urbaniak","year":"2016","unstructured":"Urbaniak C, et al. The microbiota of breast tissue and its association with breast cancer. Appl Environ Microbiol. 2016;82(16):5039\u201348.","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"2046_CR59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13073-019-0621-2","volume":"11","author":"J Allen","year":"2019","unstructured":"Allen J, Sears CL. Impact of the gut microbiome on the genome and epigenome of colon epithelial cells: contributions to colorectal cancer development. Genome Med. 2019;11(1):11.","journal-title":"Genome Med"},{"issue":"1","key":"2046_CR60","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12866-020-01739-1","volume":"20","author":"J Ma","year":"2020","unstructured":"Ma J, et al. Alter between gut bacteria and blood metabolites and the anti-tumor effects of Faecalibacterium prausnitzii in breast cancer. BMC Microbiol. 2020;20(1):82.","journal-title":"BMC Microbiol"},{"issue":"1","key":"2046_CR61","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12944-017-0593-4","volume":"16","author":"V Salimi","year":"2017","unstructured":"Salimi V, et al. Sodium butyrate promotes apoptosis in breast cancer cells through reactive oxygen species (ROS) formation and mitochondrial impairment. Lipids Health Dis. 2017;16(1):208.","journal-title":"Lipids Health Dis"},{"issue":"19","key":"2046_CR62","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.3390\/cancers17193248","volume":"17","author":"K Jaye","year":"2025","unstructured":"Jaye K, et al. Guardians in the gut: mechanistic insights into a hidden ally against triple-negative breast cancer. Cancers (Basel). 2025;17(19):3248.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2046_CR63","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41392-025-02159-1","volume":"10","author":"B Cui","year":"2025","unstructured":"Cui B, et al. Gut dysbiosis conveys psychological stress to activate LRP5\/\u03b2-catenin pathway promoting cancer stemness. Signal Transduct Target Ther. 2025;10(1):79.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"2046_CR64","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3390\/microorganisms10091727","volume":"10","author":"H Wu","year":"2022","unstructured":"Wu H, Ganguly S, Tollefsbol TO. Modulating microbiota as a new strategy for breast cancer prevention and treatment. Microorganisms. 2022;10(9):1727.","journal-title":"Microorganisms"},{"key":"2046_CR65","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.micpath.2017.07.029","volume":"110","author":"M Zhang","year":"2017","unstructured":"Zhang M, et al. Bifidobacterium longum affects the methylation level of forkhead box P3 promoter in 2, 4, 6-trinitrobenzenesulphonic acid induced colitis in rats. Microb Pathog. 2017;110:426\u201330.","journal-title":"Microb Pathog"},{"issue":"7","key":"2046_CR66","first-page":"3422","volume":"12","author":"A Schoeller","year":"2022","unstructured":"Schoeller A, et al. Short chain fatty acids exhibit selective estrogen receptor downregulator (SERD) activity in breast cancer. Am J Cancer Res. 2022;12(7):3422\u201336.","journal-title":"Am J Cancer Res"},{"issue":"2","key":"2046_CR67","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/cr.2010.118","volume":"21","author":"J Fu","year":"2011","unstructured":"Fu J, et al. The TWIST\/Mi2\/NuRD protein complex and its essential role in cancer metastasis. Cell Res. 2011;21(2):275\u201389.","journal-title":"Cell Res"},{"issue":"1","key":"2046_CR68","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13148-022-01228-4","volume":"14","author":"G Pantelaiou-Prokaki","year":"2022","unstructured":"Pantelaiou-Prokaki G, et al. HDAC8 suppresses the epithelial phenotype and promotes EMT in chemotherapy-treated basal-like breast cancer. Clin Epigenetics. 2022;14(1):7.","journal-title":"Clin Epigenetics"},{"key":"2046_CR69","doi-asserted-by":"publisher","first-page":"153396","DOI":"10.1016\/j.prp.2021.153396","volume":"220","author":"G Rahmani","year":"2021","unstructured":"Rahmani G, et al. The clinical significance of histone deacetylase-8 in human breast cancer. Pathol Res Pract. 2021;220:153396.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"2046_CR70","doi-asserted-by":"publisher","first-page":"e0210889","DOI":"10.1371\/journal.pone.0210889","volume":"14","author":"A Mrkvicova","year":"2019","unstructured":"Mrkvicova A, et al. The effect of sodium butyrate and cisplatin on expression of EMT markers. PLoS ONE. 2019;14(1):e0210889.","journal-title":"PLoS ONE"},{"key":"2046_CR71","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1477-7819-7-49","volume":"7","author":"HJ Cho","year":"2009","unstructured":"Cho HJ, et al. The combination effect of sodium butyrate and 5-Aza-2\u2032-deoxycytidine on radiosensitivity in RKO colorectal cancer and MCF-7 breast cancer cell lines. World J Surg Oncol. 2009;7:49.","journal-title":"World J Surg Oncol"},{"issue":"6","key":"2046_CR72","first-page":"985","volume":"28","author":"W Chen","year":"2011","unstructured":"Chen W, et al. Trastuzumab enhances the anti-tumor effects of the histone deacetylase inhibitor sodium butyrate on a HER2-overexpressing breast cancer cell line. Int J Mol Med. 2011;28(6):985\u201391.","journal-title":"Int J Mol Med"},{"issue":"9","key":"2046_CR73","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1590\/S0100-879X2012007500103","volume":"45","author":"FO Andrade","year":"2012","unstructured":"Andrade FO, et al. Efficacy of the dietary histone deacetylase inhibitor butyrate alone or in combination with vitamin A against proliferation of MCF-7 human breast cancer cells. Braz J Med Biol Res. 2012;45(9):841\u201350.","journal-title":"Braz J Med Biol Res"},{"issue":"10","key":"2046_CR74","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3390\/microorganisms10102048","volume":"10","author":"GH Al-Qadami","year":"2022","unstructured":"Al-Qadami GH, et al. Gut microbiota-derived short-chain fatty acids: impact on cancer treatment response and toxicities. Microorganisms. 2022;10(10):2048.","journal-title":"Microorganisms"},{"issue":"9","key":"2046_CR75","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.3390\/cancers12092465","volume":"12","author":"A Laborda-Illanes","year":"2020","unstructured":"Laborda-Illanes A, et al. Breast and gut microbiota action mechanisms in breast cancer pathogenesis and treatment. Cancers (Basel). 2020;12(9):2465.","journal-title":"Cancers (Basel)"},{"issue":"17","key":"2046_CR76","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1158\/0008-5472.CAN-23-2526","volume":"84","author":"SJ Conner","year":"2024","unstructured":"Conner SJ, et al. Obesity induces temporally regulated alterations in the extracellular matrix that drive breast tumor invasion and metastasis. Cancer Res. 2024;84(17):2761\u201375.","journal-title":"Cancer Res"},{"issue":"4","key":"2046_CR77","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.orcp.2015.08.017","volume":"10","author":"AM Assiri","year":"2016","unstructured":"Assiri AM, Kamel HF. Evaluation of diagnostic and predictive value of serum adipokines: leptin, resistin and visfatin in postmenopausal breast cancer. Obes Res Clin Pract. 2016;10(4):442\u201353.","journal-title":"Obes Res Clin Pract"},{"issue":"4","key":"2046_CR78","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/jcb.21911","volume":"105","author":"D Cirillo","year":"2008","unstructured":"Cirillo D, et al. Leptin signaling in breast cancer: an overview. J Cell Biochem. 2008;105(4):956\u201364.","journal-title":"J Cell Biochem"},{"key":"2046_CR79","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mce.2017.09.014","volume":"466","author":"C G\u00e9rard","year":"2018","unstructured":"G\u00e9rard C, Brown KA. Obesity and breast cancer - role of estrogens and the molecular underpinnings of aromatase regulation in breast adipose tissue. Mol Cell Endocrinol. 2018;466:15\u201330.","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"2046_CR80","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41388-024-02954-0","volume":"43","author":"CB Lagarde","year":"2024","unstructured":"Lagarde CB, et al. Obesity-associated epigenetic alterations and the obesity-breast cancer axis. Oncogene. 2024;43(11):763\u201375.","journal-title":"Oncogene"},{"issue":"2","key":"2046_CR81","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/curroncol31020075","volume":"31","author":"L Szablewski","year":"2024","unstructured":"Szablewski L. Insulin resistance: the increased risk of cancers. Curr Oncol. 2024;31(2):998\u20131027.","journal-title":"Curr Oncol"},{"issue":"9","key":"2046_CR82","doi-asserted-by":"publisher","first-page":"e230330","DOI":"10.1530\/ERC-23-0330","volume":"31","author":"L Zhou","year":"2024","unstructured":"Zhou L, et al. AGEs induce MMP-9 promoter demethylation through the GADD45\u03b1-mediated BER pathway to promote breast cancer metastasis in patients with diabetes. Endocr Relat Cancer. 2024;31(9):e230330.","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"2046_CR83","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.4239\/wjd.v15.i6.1187","volume":"15","author":"AC Improta-Caria","year":"2024","unstructured":"Improta-Caria AC, et al. Dysregulated microRNAs in type 2 diabetes and breast cancer: potential associated molecular mechanisms. World J Diabetes. 2024;15(6):1187\u201398.","journal-title":"World J Diabetes"},{"issue":"12","key":"2046_CR84","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1136\/gut.2010.215665","volume":"59","author":"EF Murphy","year":"2010","unstructured":"Murphy EF, et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut. 2010;59(12):1635\u201342.","journal-title":"Gut"},{"key":"2046_CR85","doi-asserted-by":"publisher","first-page":"1394719","DOI":"10.3389\/frmbi.2024.1394719","volume":"3","author":"M Gaber","year":"2024","unstructured":"Gaber M, et al. The microbiome: a link between obesity and breast cancer risk. Front Microbiol. 2024;3:1394719.","journal-title":"Front Microbiol"},{"issue":"1","key":"2046_CR86","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3892\/ijo.2023.5592","volume":"64","author":"R Kumavath","year":"2024","unstructured":"Kumavath R, et al. Effects of gut microbiome and obesity on the development, progression and prevention of cancer (Review). Int J Oncol. 2024;64(1):4.","journal-title":"Int J Oncol"},{"key":"2046_CR87","doi-asserted-by":"publisher","first-page":"102590","DOI":"10.1016\/j.ebiom.2019.11.051","volume":"51","author":"M Gurung","year":"2020","unstructured":"Gurung M, et al. Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine. 2020;51:102590.","journal-title":"EBioMedicine"},{"issue":"4","key":"2046_CR88","doi-asserted-by":"publisher","first-page":"800","DOI":"10.2174\/0929867327666200824112056","volume":"28","author":"A Gasmi","year":"2021","unstructured":"Gasmi A, et al. Obesity and insulin resistance: associations with chronic inflammation, genetic and epigenetic factors. Curr Med Chem. 2021;28(4):800\u201326.","journal-title":"Curr Med Chem"},{"issue":"7","key":"2046_CR89","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","volume":"152","author":"O Ch\u00e1vez-Talavera","year":"2017","unstructured":"Ch\u00e1vez-Talavera O, et al. Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease. Gastroenterology. 2017;152(7):1679-1694.e3.","journal-title":"Gastroenterology"},{"issue":"10","key":"2046_CR90","doi-asserted-by":"publisher","first-page":"9015","DOI":"10.3390\/ijms24109015","volume":"24","author":"H Wu","year":"2023","unstructured":"Wu H, et al. Dietary supplementation of inulin contributes to the prevention of estrogen receptor-negative mammary cancer by alteration of gut microbial communities and epigenetic regulations. Int J Mol Sci. 2023;24(10):9015.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2046_CR91","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.3390\/nu11112565","volume":"11","author":"TM Newman","year":"2019","unstructured":"Newman TM, Vitolins MZ, Cook KL. From the table to the tumor: the role of Mediterranean and western dietary patterns in shifting microbial-mediated signaling to impact breast cancer risk. Nutrients. 2019;11(11):2565.","journal-title":"Nutrients"},{"issue":"2","key":"2046_CR92","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/10408398.2022.2106180","volume":"64","author":"P Wang","year":"2024","unstructured":"Wang P, et al. Targeting microbiota-host interactions with resveratrol on cancer: effects and potential mechanisms of action. Crit Rev Food Sci Nutr. 2024;64(2):311\u201333.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"11","key":"2046_CR93","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1080\/10408398.2013.789823","volume":"56","author":"JM Landete","year":"2016","unstructured":"Landete JM, et al. Bioactivation of phytoestrogens: intestinal bacteria and health. Crit Rev Food Sci Nutr. 2016;56(11):1826\u201343.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"9","key":"2046_CR94","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1021\/acs.jafc.2c08889","volume":"71","author":"CE Iglesias-Aguirre","year":"2023","unstructured":"Iglesias-Aguirre CE, et al. Gut bacteria involved in ellagic acid metabolism to yield human urolithin metabotypes revealed. J Agric Food Chem. 2023;71(9):4029\u201335.","journal-title":"J Agric Food Chem"},{"key":"2046_CR95","doi-asserted-by":"publisher","first-page":"625782","DOI":"10.3389\/fmicb.2021.625782","volume":"12","author":"S Molino","year":"2021","unstructured":"Molino S, et al. Enrichment of food with tannin extracts promotes healthy changes in the human gut microbiota. Front Microbiol. 2021;12:625782.","journal-title":"Front Microbiol"},{"issue":"23","key":"2046_CR96","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.3390\/foods11233775","volume":"11","author":"X Li","year":"2022","unstructured":"Li X, et al. Microorganisms-an effective tool to intensify the utilization of sulforaphane. Foods. 2022;11(23):3775.","journal-title":"Foods"},{"key":"2046_CR97","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jnutbio.2018.09.015","volume":"63","author":"JL Kaczmarek","year":"2019","unstructured":"Kaczmarek JL, et al. Broccoli consumption affects the human gastrointestinal microbiota. J Nutr Biochem. 2019;63:27\u201334.","journal-title":"J Nutr Biochem"},{"issue":"20","key":"2046_CR98","doi-asserted-by":"publisher","first-page":"7067","DOI":"10.1080\/10408398.2023.2180478","volume":"64","author":"C Liu","year":"2024","unstructured":"Liu C, et al. Gut microbiota-mediated metabolism of green tea catechins and the biological consequences: An updated review. Crit Rev Food Sci Nutr. 2024;64(20):7067\u201384.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"13","key":"2046_CR99","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.3390\/molecules26133907","volume":"26","author":"S P\u00e9rez-Burillo","year":"2021","unstructured":"P\u00e9rez-Burillo S, et al. Green tea and its relation to human gut microbiome. Molecules. 2021;26(13):3907.","journal-title":"Molecules"},{"issue":"5","key":"2046_CR100","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3390\/nu14051013","volume":"14","author":"M Yao","year":"2022","unstructured":"Yao M, et al. Gut microbiota composition in relation to the metabolism of oral administrated resveratrol. Nutrients. 2022;14(5):1013.","journal-title":"Nutrients"},{"key":"2046_CR101","doi-asserted-by":"publisher","first-page":"129532","DOI":"10.1016\/j.foodchem.2021.129532","volume":"357","author":"B Zhang","year":"2021","unstructured":"Zhang B, et al. Intestinal pharmacokinetics of resveratrol and regulatory effects of resveratrol metabolites on gut barrier and gut microbiota. Food Chem. 2021;357:129532.","journal-title":"Food Chem"},{"issue":"11","key":"2046_CR102","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.3390\/nu13113944","volume":"13","author":"M Sharma","year":"2021","unstructured":"Sharma M, et al. Therapeutic effects of dietary soybean genistein on triple-negative breast cancer via regulation of epigenetic mechanisms. Nutrients. 2021;13(11):3944.","journal-title":"Nutrients"},{"issue":"5","key":"2046_CR103","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/gcc.22154","volume":"53","author":"Q Xie","year":"2014","unstructured":"Xie Q, et al. Genistein inhibits DNA methylation and increases expression of tumor suppressor genes in human breast cancer cells. Genes Chromosomes Cancer. 2014;53(5):422\u201331.","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"2046_CR104","doi-asserted-by":"publisher","first-page":"113160","DOI":"10.1016\/j.yexcr.2022.113160","volume":"416","author":"M Sharma","year":"2022","unstructured":"Sharma M, Tollefsbol TO. Combinatorial epigenetic mechanisms of sulforaphane, genistein and sodium butyrate in breast cancer inhibition. Exp Cell Res. 2022;416(1):113160.","journal-title":"Exp Cell Res"},{"issue":"1","key":"2046_CR105","doi-asserted-by":"publisher","first-page":"e54369","DOI":"10.1371\/journal.pone.0054369","volume":"8","author":"Y Li","year":"2013","unstructured":"Li Y, et al. Epigenetic regulation of multiple tumor-related genes leads to suppression of breast tumorigenesis by dietary genistein. PLoS ONE. 2013;8(1):e54369.","journal-title":"PLoS ONE"},{"issue":"5","key":"2046_CR106","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s12282-018-0866-4","volume":"25","author":"MS Jaman","year":"2018","unstructured":"Jaman MS, Sayeed MA. Ellagic acid, sulforaphane, and ursolic acid in the prevention and therapy of breast cancer: current evidence and future perspectives. Breast Cancer. 2018;25(5):517\u201328.","journal-title":"Breast Cancer"},{"issue":"3","key":"2046_CR107","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.foodchem.2011.09.109","volume":"131","author":"AK Kiss","year":"2012","unstructured":"Kiss AK, et al. Epigenetic modulation of mechanisms involved in inflammation: influence of selected polyphenolic substances on histone acetylation state. Food Chem. 2012;131(3):1015\u201320.","journal-title":"Food Chem"},{"issue":"5","key":"2046_CR108","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.3390\/ijms18051092","volume":"18","author":"KJ Royston","year":"2017","unstructured":"Royston KJ, et al. A novel combination of withaferin A and sulforaphane inhibits epigenetic machinery, cellular viability and induces apoptosis of breast cancer cells. Int J Mol Sci. 2017;18(5):1092.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2046_CR109","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/jn\/nxaa315","volume":"151","author":"S Li","year":"2021","unstructured":"Li S, Wu H, Tollefsbol TO. Combined broccoli sprouts and green tea polyphenols contribute to the prevention of estrogen receptor-negative mammary cancer via cell cycle arrest and inducing apoptosis in HER2\/neu mice. J Nutr. 2021;151(1):73\u201384.","journal-title":"J Nutr"},{"issue":"16","key":"2046_CR110","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.3390\/molecules24162899","volume":"24","author":"J Sheng","year":"2019","unstructured":"Sheng J, et al. The inhibitory effect of (-)-epigallocatechin-3-gallate on breast cancer progression via reducing SCUBE2 methylation and DNMT activity. Molecules. 2019;24(16):2899.","journal-title":"Molecules"},{"issue":"8","key":"2046_CR111","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.3390\/ijms19082204","volume":"19","author":"Y Gao","year":"2018","unstructured":"Gao Y, Tollefsbol TO. Combinational proanthocyanidins and resveratrol synergistically inhibit human breast cancer cells and impact epigenetic\u207bmediating machinery. Int J Mol Sci. 2018;19(8):2204.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2046_CR112","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/nu16050699","volume":"16","author":"L Kurzava Kendall","year":"2024","unstructured":"Kurzava Kendall L, et al. Epigenetic effects of resveratrol on oncogenic signaling in breast cancer. Nutrients. 2024;16(5):699.","journal-title":"Nutrients"},{"issue":"12","key":"2046_CR113","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s11864-022-01027-2","volume":"23","author":"J Zhang","year":"2022","unstructured":"Zhang J, et al. Cancer immunotherapy: fecal microbiota transplantation brings light. Curr Treat Options Oncol. 2022;23(12):1777\u201392.","journal-title":"Curr Treat Options Oncol"},{"issue":"6","key":"2046_CR114","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.euf.2024.12.009","volume":"10","author":"E Rafie","year":"2024","unstructured":"Rafie E, et al. What is the role of fecal microbiota transplantation in immunotherapy trials? Current perspectives and future directions. Eur Urol Focus. 2024;10(6):882\u20135.","journal-title":"Eur Urol Focus"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-025-02046-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-02046-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-02046-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T13:02:55Z","timestamp":1772629375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13148-025-02046-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,25]]},"references-count":114,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2046"],"URL":"https:\/\/doi.org\/10.1186\/s13148-025-02046-0","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,25]]},"assertion":[{"value":"22 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}